tradingkey.logo
tradingkey.logo

Trinity Biotech Announces Collaboration With University At Buffalo To Commercialize Novel Biomarkers For Sjögren’S Syndrome

ReutersMar 18, 2026 12:34 PM

- Trinity Biotech PLC TRIB.O:

  • TRINITY BIOTECH ANNOUNCES COLLABORATION WITH UNIVERSITY AT BUFFALO TO COMMERCIALIZE NOVEL BIOMARKERS FOR SJÖGREN’S SYNDROME

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI